$0.4000
-0.0254-5.97%
Last update: Nov 2, 5:29 PM
Oncolytics Biotech Inc (ONCY) Stock Price, Quote, News & History
ONCYNASDAQ
Oncolytics shares rise as pelareorep shows 19.5-month response durability and higher response rates in colorectal cancer study.
You can purchase shares of Oncolytics Biotech (NASDAQ:ONCY) through any online brokerage.
Other companies in Oncolytics Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Oncolytics Biotech has a consensus price target of $4.67.
The stock price for Oncolytics Biotech (NASDAQ: ONCY) is $0.4 last updated November 2, 2026 at 5:29 PM EST.
There are no upcoming dividends for Oncolytics Biotech.
Oncolytics Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Oncolytics Biotech.
Oncolytics Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing...
